Webinar: The Specialty LOE Wave

February 16, 2023 – OnDemand 

Biosimilars and specialty generics are the new hot ticket for the pharma industry. However, there may be a rocky road ahead. In this session, Jason Bogroff, Senior Principal, Blue Fin Group discussed:

  • The coming specialty LOE wave
  • Lessons learned from biosimilar and specialty generic launches
  • Insights from a similar inflection point in 2010+
  • How the specialty LOE wave may play out and the implications across payers, pharmacies, providers, and patients. 
  • What you can do to prepare

Learn more about our strategic consulting solutions for effective commercialization and improved market access.


Jason Bogroff
Senior Principal, Blue Fin Group

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article